Allis, Charles David
- Weill Cornell Medicine · Pathology (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
FY2021 NIH rank #15,971
- Sustained Excellence
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award categories
- Pathology
NIH Funding · FY2021
Linked Award Amount
$664.9K
Full award amounts, FY2021
Award Records
1
Records listing this PI
Award-Linked Rank
#15,971
By linked amount among FY2021 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2021 award records by amount
NIH award records listing Allis, Charles David as a PI. Multi-PI records show the full award amount for context.
- 5R01CA234561-03R01Contact PIRole of novel onco-histone mutations in B-cell malignanciesWeill Cornell Medicine · Pathology (NIH department code)$664.9Kaward amount
Award organization
Organizations that administered FY2021 awards listing Allis, Charles David as a PI.
FY2021 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardWeill Cornell Medicine
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #3093
- 2001Entered Top 25% NationallyRanked #3093
- 2002$2M Cumulative Funding
- 2004R01 Grant Holder
- 2005$5M Cumulative Funding
- 2021$10M Cumulative Funding